Nature Biotechnology devoted an editorial to the positive contribution CRISPR can make to the democratization of agricultural biotechnology. The hope is that, without the burden of overregulation, even public institutes and small biotech companies can bring useful products from the lab to the fields. Gene editing without the introduction of “trans” sequences from other species can be given the suffix “cis,” hence the title of the article, Cis-editing for all.